Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 741 - 760 results of 102,530 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.89s Refine Results
  1. 741
    The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6.

    The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6. by Leda Castaño Barrios (8524317)

    Published 2021
    Save to List
    Saved in:
  2. 742
    Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R.

    Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R. by Patricia de Godoy Bueno (731717)

    Published 2015
    Save to List
    Saved in:
  3. 743
    Fluoxetine decreases TOPFlash firefly luciferase reporter activity.

    Fluoxetine decreases TOPFlash firefly luciferase reporter activity. by Kentaro Miyamoto (123271)

    Published 2017
    Save to List
    Saved in:
  4. 744
    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.

    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

    Published 2024
    Save to List
    Saved in:
  5. 745
    Fig 5 -

    Fig 5 - by Mary J. Obayemi (11813022)

    Published 2021
    Save to List
    Saved in:
  6. 746
    Reduced ADAMTS-12 expression levels decrease EVT invasion.

    Reduced ADAMTS-12 expression levels decrease EVT invasion. by Alexander G. Beristain (225001)

    Published 2011
    Save to List
    Saved in:
  7. 747
    Higher baseline PV rates decrease the need for interneuron specialization.

    Higher baseline PV rates decrease the need for interneuron specialization. by Joram Keijser (12475353)

    Published 2022
    Save to List
    Saved in:
  8. 748
    NETs decrease <i>T</i>. <i>cruzi</i> infectivity.

    NETs decrease <i>T</i>. <i>cruzi</i> infectivity. by Daniel Sousa-Rocha (802734)

    Published 2015
    Save to List
    Saved in:
  9. 749
    Early increase and later decrease in GSK-3β activity.

    Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

    Published 2013
    Save to List
    Saved in:
  10. 750
    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice.

    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 751
    Table_5_Episodic Decrease in Temperature Increases mcy Gene Transcription and Cellular Microcystin in Continuous Cultures of Microcystis aeruginosa PCC 7806.XLSX

    Table_5_Episodic Decrease in Temperature Increases mcy Gene Transcription and Cellular Microcystin in Continuous Cultures of Microcystis aeruginosa PCC 7806.XLSX by Robbie M. Martin (4686418)

    Published 2020
    Save to List
    Saved in:
  12. 752
    Decrease of actin velocity when passing confined TCR clusters.

    Decrease of actin velocity when passing confined TCR clusters. by Cheng-han Yu (244912)

    Published 2010
    Save to List
    Saved in:
  13. 753
    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA.

    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 754
    Fig 5 -

    Fig 5 - by Jacob C. Jentzer (4746999)

    Published 2022
    Save to List
    Saved in:
  15. 755
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 756
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 757
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 758
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 759
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 760
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: